Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.
Neuralink, which company received Food and Drug Administration clearance in May 2023 to launch human trials, has so far only ...
Like the US study, the CAN-PRIME Neuralink trial will only consider patients who can't use their hands and is designed to ...